🇺🇸 FDA
Patent

US 11667662

Modulators of 5′-nucleotidase, ecto and the use thereof

granted A61KA61K31/70A61K31/7052

Quick answer

US patent 11667662 (Modulators of 5′-nucleotidase, ecto and the use thereof) held by Arcus Biosciences, Inc. expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Arcus Biosciences, Inc.
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/70, A61K31/7052, A61K31/706, A61K31/7064